These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1677313)

  • 61. The platelet-stimulating effect of adrenaline through alpha 2-adrenergic receptors requires simultaneous activation by a true stimulatory platelet agonist. Evidence that adrenaline per se does not induce human platelet activation in vitro.
    Steen VM; Holmsen H; Aarbakke G
    Thromb Haemost; 1993 Sep; 70(3):506-13. PubMed ID: 8259557
    [TBL] [Abstract][Full Text] [Related]  

  • 62. In vitro studies of the effect of buflomedil on platelet responsiveness.
    Ryckewaert JJ; Maurel A; Marguerie G
    Haemostasis; 1990; 20(3):181-91. PubMed ID: 1974871
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Blood platelet adrenoceptor: aggregatory and antiaggregatory activity of imidazoline drugs.
    Petrusewicz J; Kaliszan R
    Pharmacology; 1986; 33(5):249-55. PubMed ID: 3797465
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Epinephrine-induced aggregation of rabbit platelets refractory to ADP.
    Lalau Keraly C; Kinlough-Rathbone RL; Mustard JF
    Thromb Haemost; 1985 Jun; 53(3):366-71. PubMed ID: 2996167
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Studies on the inhibition of adrenaline-induced aggregation of blood platelets.
    Glusa E; Markwardt F; Barthel W
    Pharmacology; 1979; 19(4):196-201. PubMed ID: 42933
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Activation of the alpha(2A)-adrenoceptor mediates deceleration of the deaggregation component of the response to ADP or 5-HT in human platelets in vitro.
    Maayani S; Schwarz T; Craddock-Royal B; Tagliente TM
    Platelets; 2001 Sep; 12(6):359-75. PubMed ID: 11672475
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Heterogeneity of alpha 2-adrenoceptors in rat cortex but not human platelets can be defined by 8-OH-DPAT, RU 24969 and methysergide.
    Brown CM; MacKinnon AC; McGrath JC; Spedding M; Kilpatrick AT
    Br J Pharmacol; 1990 Mar; 99(3):481-6. PubMed ID: 1970497
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Difference in inhibitory actions of products of the myeloperoxidase- catalyzed reaction on initial aggregation of activated platelets].
    Rpshchupkin DI; Berzhitskaia VV; Murina MA
    Biofizika; 1998; 43(2):323-8. PubMed ID: 9591107
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Anti-aggregation effect of aroxyalkyl derivatives of 2-methoxyphenylpiperazine is due to their 5-HT
    Kubacka M; Kazek G; Kotańska M; Filipek B; Waszkielewicz AM; Mogilski S
    Eur J Pharmacol; 2018 Jan; 818():263-270. PubMed ID: 29111111
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Characterization of alpha 2-adrenoceptors on blood platelets from various species using 3H-yohimbine.
    Glusa E; Markwardt F
    Haemostasis; 1983; 13(2):96-101. PubMed ID: 6307838
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Novel alpha2-adrenoreceptors primarily responsible for inducing human platelet aggregation.
    Grant JA; Scrutton MC
    Nature; 1979 Feb; 277(5698):659-61. PubMed ID: 34106
    [No Abstract]   [Full Text] [Related]  

  • 72. Maternal and fetal platelet responses and adrenoceptor binding characteristics.
    Jones CR; McCabe R; Hamilton CA; Reid JL
    Thromb Haemost; 1985 Feb; 53(1):95-8. PubMed ID: 2986310
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Influence of adrenergic neuron blocking agents on the adrenaline-induced platelet reactions.
    Glusa E; Markwardt F
    Acta Biol Med Ger; 1982; 41(6):565-9. PubMed ID: 6128849
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The role of alpha 1-adrenoceptors in adrenaline-induced hyperkalaemia.
    Ensinger H; Dirks B; Altemeyer KH; Grünert A
    Br J Anaesth; 1990 Dec; 65(6):786-90. PubMed ID: 1979911
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Impact of treatment with acetylsalicylic acid on the proaggregatory effects of adrenaline in vitro in patients with stable angina pectoris: influence of the anticoagulant.
    Wallén NH; Held C; Rehnqvist N; Hjemdahl P
    Clin Sci (Lond); 1993 Nov; 85(5):577-83. PubMed ID: 8287646
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effects of alpha 2-adrenoceptor agonists and of related compounds on aggregation of, and on adenylate cyclase activity in, human platelets.
    Clare KA; Scrutton MC; Thompson NT
    Br J Pharmacol; 1984 Jun; 82(2):467-76. PubMed ID: 6145472
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Human blood platelet alpha adrenoceptor in view of the effects of various imidazol(in)e drugs on aggregation.
    Petrusewicz J; Kaliszan R
    Gen Pharmacol; 1991; 22(5):819-23. PubMed ID: 1662170
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effects of adrenaline and alpha adrenergic antagonists on platelet aggregation in whole blood: evaluation of electrical impedance aggregometry.
    Swart SS; Pearson D; Wood JK; Barnett DB
    Thromb Res; 1984 Dec; 36(5):411-8. PubMed ID: 6151753
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Guanabenz, an antihypertensive centrally acting alpha2-agonist, suppresses morning elevations in aggregation of human platelets.
    Hayashi J; Sato H; Tanaka Y; Tokuue J; Ishida N; Watanabe K; Kitamoto K
    J Cardiovasc Pharmacol; 2001 Jan; 37(1):89-93. PubMed ID: 11152378
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Experimental approach to differentiation of the effects mediated by imidazole receptors and alpha2-adrenoceptors on platelets.
    Ponomarev VV; Galenko-Yaroshevskii AP; Dukhanin AS
    Bull Exp Biol Med; 2003 Jun; 135(6):570-2. PubMed ID: 12937676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.